Literature DB >> 24123012

Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.

Risako Hiraga1, Masayoshi Kato, Shinichi Miyagawa, Tohru Kamata.   

Abstract

UNLABELLED: Transforming growth factor (TGF)-β induces epithelial-mesenchymal transition (EMT) in pancreatic adenocarcinoma. In this study, we investigated how NADPH oxidase (Nox) 4-generated reactive oxygen species (ROS) regulate TGF-β-induced EMT in pancreatic cancer cells.
MATERIALS AND METHODS: Pancreatic cancer cells were transfected with Nox4 siRNAs or PTP1B mutants and subjected to TGF-β-induced EMT assay. Expression of Nox4, TGF-β, and N-cadherin was immunohistochemically-examined with patient tumor samples.
RESULTS: Treatment of pancreatic cancer cells with TGF-β induced Nox4 expression, indicating that Nox4 represents a major source for ROS production. The Nox4 inhibitor diphenylene iodonium and Nox4 siRNAs blocked TGF-β-induced EMT phenotype including morphological changes, augmented migration, and altered expression of E-cadherin and Snail. Furthermore, PTP1B as a redox-sensor for Nox4-derived ROS participated in TGF-β-promoted EMT. Nox4, TGF-β, and N-cadherin were up-regulated in tumors from pancreatic cancer patients.
CONCLUSIONS: These findings suggest that Nox4-derived ROS, at least in part, transmit TGF-β-triggered EMT signals through PTP1B in pancreatic cancer.

Entities:  

Keywords:  EMT; Nox4; TGF-β; pancreatic cancer

Mesh:

Substances:

Year:  2013        PMID: 24123012

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  55 in total

Review 1.  ROS signaling and redox biology in endothelial cells.

Authors:  Emiliano Panieri; Massimo M Santoro
Journal:  Cell Mol Life Sci       Date:  2015-05-14       Impact factor: 9.261

2.  Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.

Authors:  Qing-Hui Zhang; Yong-Liang Yao; Xiao-Yang Wu; Jian-Hong Wu; Tao Gu; Ling Chen; Jin-Hua Gu; Yun Liu; Ling Xu
Journal:  Dig Dis Sci       Date:  2015-02-05       Impact factor: 3.199

3.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

Review 4.  Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

Authors:  Agnieszka Anna Rucki; Lei Zheng
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.

Authors:  Bing Tian; Yingxin Zhao; Hong Sun; Yueqing Zhang; Jun Yang; Allan R Brasier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-28       Impact factor: 5.464

Review 6.  Targeting reactive oxygen species in development and progression of pancreatic cancer.

Authors:  Nisha Durand; Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2016-11-23       Impact factor: 4.512

7.  Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling.

Authors:  Bing Tian; Koa Hosoki; Zhiqing Liu; Jun Yang; Yingxin Zhao; Hong Sun; Jia Zhou; Erik Rytting; Lata Kaphalia; William J Calhoun; Sanjiv Sur; Allan R Brasier
Journal:  J Allergy Clin Immunol       Date:  2018-10-13       Impact factor: 10.793

8.  Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.

Authors:  Carmen Veith; Agnes W Boots; Musa Idris; Frederik-Jan van Schooten; Albert van der Vliet
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

9.  RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling.

Authors:  Xiang Gao; Jingping Sun; Chunyu Huang; Xiaohua Hu; Ning Jiang; Chenqi Lu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

10.  TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.

Authors:  A K Thakur; J Nigri; S Lac; J Leca; C Bressy; P Berthezene; L Bartholin; P Chan; E Calvo; J L Iovanna; S Vasseur; F Guillaumond; R Tomasini
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.